“We are happy that our strong IP protection remains in force and we look forward to the continued development of nadunolimab for treatment of cancer” said Göran Forsberg, CEO of
In
© Modular Finance, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.678 SEK | +1.83% | -3.77% | +23.06% |
12:05pm | Cantargia Appoints New Chief Business Officer | MT |
07:30am | Cantargia AB Announces Appointment of Ton Berkien as Chief Business Officer, Effective October 1, 2024 | CI |
“We are happy that our strong IP protection remains in force and we look forward to the continued development of nadunolimab for treatment of cancer” said Göran Forsberg, CEO of
In
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
+23.06% | 80.33M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.71% | 22.39B | |
-11.76% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |